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ABSTRACT The mechanical characteristics of smooth muscle can be broadly defined as either phasic, or fast contracting,
and tonic, or slow contracting (Somlyo and Somlyo, 1968, Pharmacol. Rev. 20:197–272). To determine if differences in the
cross-bridge cycle and/or distribution of the cross-bridge states could contribute to differences in the mechanical properties
of smooth muscle, we determined force and stiffness as a function of frequency in Triton-permeabilized strips of rabbit portal
vein (phasic) and aorta (tonic). Permeabilized muscle strips were mounted between a piezoelectric length driver and a
piezoresistive force transducer. Muscle length was oscillated from 1 to 100 Hz, and the stiffness was determined as a function
of frequency from the resulting force response. During calcium activation (pCa 4, 5 mM MgATP), force and stiffness increased
to steady-state levels consistent with the attachment of actively cycling cross-bridges. In smooth muscle, because the
cross-bridge states involved in force production have yet to be elucidated, the effects of elevation of inorganic phosphate (Pi)
and MgADP on steady-state force and stiffness were examined. When portal vein strips were transferred from activating
solution (pCa 4, 5 mM MgATP) to activating solution with 12 mM Pi, force and stiffness decreased proportionally, suggesting
that cross-bridge attachment is associated with Pi release. For the aorta, elevating Pi decreased force more than stiffness,
suggesting the existence of an attached, low-force actin-myosin-ADP- Pi state. When portal vein strips were transferred from
activating solution (pCa 4, 5 mM MgATP) to activating solution with 5 mM MgADP, force remained relatively constant, while
stiffness decreased50%. For the aorta, elevating MgADP decreased force and stiffness proportionally, suggesting for tonic
smooth muscle that a significant portion of force production is associated with ADP release. These data suggest that in the
portal vein, force is produced either concurrently with or after Pi release but before MgADP release, whereas in aorta, MgADP
release is associated with a portion of the cross-bridge powerstroke. These differences in cross-bridge properties could
contribute to the mechanical differences in properties of phasic and tonic smooth muscle.
INTRODUCTION
In the 1970s it was recognized that smooth muscle mechan-
ics could be modeled using the same sliding filament/cross-
bridge population paradigms as those for striated muscle
(Huxley and Simmons, 1971). Although smooth muscle and
skeletal muscle have similar basic mechanisms, there are
crucial differences between the two that define their indi-
vidual characteristics. Mechanically, smooth muscle is
broadly categorized as either phasic or tonic (Somlyo and
Somlyo, 1968). Phasic smooth muscle is characterized by
relatively rapid rates of force activation and relaxation, high
actomyosin ATPase activity, and a fast maximum velocity
of muscle shortening (vmax). On the other hand, tonic
smooth muscle has relatively slow rates of force activation
and relaxation, a slow actomyosin ATPase, and a slow vmax.
There are also differences in the splice variant expression of
the myosin heavy chain (Kelley et al., 1993) and essential
light chain (MLC17) isoforms (Nabeshima et al., 1987)
between phasic and tonic smooth muscle (Szymanski et al.,
1998). These structural differences are thought to lead to
differences in distribution and kinetics of the cross-bridge
cycle (Morano et al., 1997) and the ADP affinity of the
cross-bridge (Fuglsang et al., 1993; Nishiye et al., 1993;
Khromov et al., 1995).
Traditionally, the quick release methods of force clamps
(Hill, 1938) and length steps (Huxley and Simmons, 1971)
have been used to investigate cross-bridge properties. In
1980, Kawai and Brandt developed a method that expanded
this basic concept to the detection of shifts in the cross-
bridge population, using separate, fixed-frequency sine
wave measurements or fixed-frequency sinusoidal length
perturbations. The fixed-frequency sinusoidal length pertur-
bation protocol has a major advantage over traditional meth-
ods in that it is able to detect shifts in the cross-bridge
population (Kawai and Zhao, 1993). However, this method
requires multiple contraction and relaxation cycles, result-
ing in limited temporal resolution because the stiffness is
determined separately at each frequency. To increase the
accuracy, frequency, and temporal resolution of the fixed-
frequency sinusoidal length perturbation protocol, a novel
length perturbation protocol was recently developed in our
laboratory that combined and linked linearly increasing
multiplet sine waves or increasing multi-sine-wave length
perturbation protocols (Shue and Brozovich, 1999). In tis-
sue strip preparations, the increasing multi-sine-wave length
perturbation protocol yields a linear frequency response of
1–100 Hz with a frequency resolution of 1 Hz and a tem-
poral resolution of 14 s.
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Energy transduction in muscle is accomplished by a
cyclic interaction between the globular head of myosin
interacting with actin in the thin filaments. Relaxed muscle
contains predominantly detached or weakly attached cross-
bridges with bound products of ATP hydrolysis (refer to
Fig. 1, state a). Upon activation, the cross-bridge attaches to
the actin filament and tilts, to produce the sliding force
between the thick and thin filaments. Force generation has
been associated primarily with the release of Pi from the
active site in smooth muscle (Fig. 1, step 4; Osterman and
Arner, 1995; He et al., 1998). X-ray diffraction has pre-
dicted that the release of Pi from the active site results in
local rearrangements of the protein structure near the active
site, translating into a 5–20-nm movement of the light chain
region at the head-rod junction (Rayment et al., 1993).
However, in smooth muscle, force generation may also be
associated with ADP release (Fig. 1, step 6; Whittaker et al.,
1995; Gollub et al., 1996). The release of ADP from the S1
nucleotide binding cleft results in the 23° movement of
the light chain binding helix, resulting in a 35-Å move-
ment of the last heavy chain residue. After ADP release
(Fig. 1, step 6) in the presence of MgATP, there is rapid
ATP binding (Fig. 1, step 1) that induces cross-bridge
detachment (Fig. 1, step 2). Hydrolysis of ATP by the S1
head reforms actinmyosin-ADP- Pi (AM-ADP-Pi) (Fig.
1, step 3). Evidence suggests that two A-M-ADP-Pi states
are present in skeletal muscle, and force is thought to occur
during a rapid isomerization that immediately precedes Pi
release (Geeves, 1991; Kawai and Halvorson, 1991;
Dantzig et al., 1992). However, we have not included this
state (A-M-ADP- Pi) in the scheme because there is no
experimental evidence that it exists in smooth muscle (Fugl-
sang et al., 1993).
We chose to investigate the cross-bridge cycle in smooth
muscle to determine if differences exist between tonic and
phasic smooth muscle. In skinned smooth muscle, we rea-
soned that if an elevation of Pi changes the distribution of
the cross-bridge states and increases the relative population
of the AM-ADP-Pi state (Fig. 1, state a), then an increase
in MgADP should similarly result in an increase in the
relative population of the A-M-ADP state(s) (Fig. 1, states
b and c). Furthermore, if force generation is coincident with
the release of Pi, elevation of Pi should result in a similar fall
in both force and stiffness. However, if ADP release is
associated with force production, an elevation of MgADP
should produce a decrease in force with little to no change
in muscle stiffness. To determine if there are differences in
the distribution of the cross-bridge states that could contrib-
ute to the mechanical differences between phasic and tonic
smooth muscle, we characterized phasic and tonic smooth
muscles by using increasing multi-sine-wave length pertur-
bations of muscle length during the steady state for relaxed,
activated, and rigor states of permeabilized smooth muscle
strips. We then examined the changes in force and stiffness
that occur when the relative distributions of cross-bridge
states are perturbed with the elevation of Pi or MgADP.
MATERIALS AND METHODS
Muscle preparation
The portal vein and aorta were removed from 4–6- kg adult New Zealand
white rabbits. The smooth muscles were quickly removed, rinsed in phys-
iological saline solution several times, and stored in oxygenated, 4°C
physiological saline solution for up to 8 h. Fat and connective tissue were
removed, and small smooth muscle strips (0.75  1.0 mm) were dis-
sected from the portal vein and aorta and attached to aluminum T-clips
(Goldman and Simmons, 1984). The portal vein and aortic membranes
were chemically permeabilized in relaxing solution containing 1% Triton
(Sigma UltraPure; Table 1) at 25°C for 45 and 105 min, respectively. The
permeabilized tissue was removed from the detergent and rinsed with
relaxing solution before it was mounted on the experimental apparatus.
The experimental apparatus
Measurements of fiber mechanics were made on an experimental apparatus
similar to that described by Smith and Barsotti (1993). The muscle was
mounted between a solid-state force transducer (AE801; Sensonor, Horten,
Norway) and a piezoelectric stack length driver (Physiks Instruments,
Walbronn, Germany). Two small hooks were fashioned from 50-m-
diameter stainless steel rods and connected to both the force transducer and
the piezoelectric length driver. The length driver was controlled through an
amplifier interfaced with a computer, using a National Instrument D/A and
A/D data acquisition board (PCI-MIO-16XE-10; 100 kS/S, 16-bit; National
Instruments). The frequency response of the force transducer, hooks, and
attached muscle was 2 kHz. The tissue was bathed in 200-l wells of a
rotating Teflon platform, and the solutions were changed using a stepped,
optical feedback-looped motor. The length driver, force transducer, and
rotating stage were mounted on an aluminum platform on a vibration
isolation table (Micro-G; TMC, Peabody, MA) inside an electrically
grounded cage.
Increasing frequency sinusoidal sequence
The length perturbation sequence combined 4 cycles/frequency of a
5.3-m (0.7% total tissue length, Lo) peak-to-peak sine wave ramping from
1 to 100 Hz in 1-Hz increments. The end of each series was padded with
0.36 s of zeroes to create a total sequence length of 14 s. After Fourier
transformation, the sequence yielded a frequency response with a 100-Hz
bandwidth at 1-Hz resolution (Shue and Brozovich, 1999). The sine waves
FIGURE 1 Proposed cross-bridge model for smooth muscle (Fuglsang et
al., 1993), as adopted from Marston and Taylor (1980) and Hibberd and
Trentham (1986).
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were generated at 4 kHz, and the resultant force and length of the tissue
during length perturbation were sampled at 4 kHz. Data were collected
during the steady state of the force response after solution changes. The
length perturbation sequence was continuously applied for 14 s and aver-
aged over five consecutive trials to reduce the influence of noise on the
frequency response of muscle stiffness measurements.
For both preparations (portal vein and aorta), Lo averaged 130% of the
resting length (data not shown), and thus in these experiments, the prepa-
rations were stretched to Lo. We have shown that stiffness is constant for
length changes between 0.5% and 2.0% of Lo in tissue strips, and at length
changes larger than 2% Lo, force and stiffness fell, suggesting that the
perturbations detached cross-bridges (data not shown). Similar experiments
in single smooth muscle cells show that stiffness is constant for length
changes smaller than 1.3% of cell length (Shue and Brozovich, 1999). In
addition, the intercept of stiffness determined from quick release experi-
ments in single smooth muscle cells has been reported to be 1.5%
(Warshaw and Fay, 1983), further suggesting that a 0.7% oscillation would
not result in the detachment of attached cross-bridges. For each experi-
ment, force and stiffness in relaxing solution were set at zero and used as
the reference for the frequency response of all other states.
Chemicals and solutions
Solutions and calcium buffers were mixed according to a computer pro-
gram that calculates a given set of free ion concentrations for the amount
of stock solutions to be mixed (Brozovich and Yamakawa, 1995). The
binding constants for the ionic species were corrected for both temperature
and ionic strength (Andrews et al., 1991); the composition of the solutions
is listed in Table 1. The solutions were adjusted to pH 7.1, with a final ionic
strength of 200 mM. All experiments were performed at room temperature
(22°C).
RESULTS
Relaxed state
The relaxed state was obtained after stretching the tissue to
Lo, changing the well solution three times with fresh relax-
ing solution, and allowing the preparation to equilibrate.
After steady state was reached, force and stiffness were
determined as a function of frequency (see Materials and
Methods). The relaxed state was characterized by low force
and low stiffness for both the portal vein and aorta (Fig. 2)
and is consistent with previously published reports (Martin
and Barsotti, 1994; Khromov et al., 1996). It has been
suggested that attached cross-bridges are present in relaxed
smooth muscle. To investigate this possibility we used
ATP--S, a nonhydrolyzable ATP analog that shifts the
population of cross-bridges to the detached AM-ATP--S
state (Goody et al., 1980). The ATPase/ADPase apyrase
(Barsotti and Ferenczi, 1988; Nishiye et al., 1993) was also
added to the ATP--S relaxing solution to remove contam-
inating endogenous ATP and ADP from permeabilized fi-
bers. Using thin-layer chromatography, we demonstrated
that a 5-min treatment of ATP--S relaxing solution with
apyrase eliminated contaminating ADP but did not hydro-
lyze ATP--S (data not shown). Upon transfer from relax-
ing solution to ATP--S relaxing solution with apyrase, the
portal vein did not exhibit a significant change in stiffness
(1  1%, n  4, Fig. 3 a). However, in the aorta, the
transfer from relaxing solution to ATP--S relaxing solution
with apyrase decreased stiffness (33  4%, n  3, Fig. 3
b), suggesting that for aortic smooth muscle in relaxing
solution, there exists a population of attached cross-bridges.
Rigor state
The rigor (A-M) state was achieved by incubating the portal
vein or aorta in rigor solution for at least 1 h while changing
to fresh rigor solution every 15 min. After this protocol in
rigor solution, stiffness was determined for the portal vein
and aorta. As reported by others (Kawai and Brandt, 1980),
we expected the rigor (A-M) state to be characterized by a
constant stiffness-versus-frequency profile over the mea-
sured frequencies. The portal vein demonstrated a flat and
constant stiffness profile. On the other hand, the aorta did
not display these “rigor” characteristics; but instead, stiff-
ness was not constant for all frequencies of oscillation. This
suggests that for the aorta in rigor solution, not all cross-
bridges populate the rigor (A-M) state. To test for the
presence of a cross-bridge population other than A-M in
rigor solution for both the portal vein and aorta, we utilized
TABLE 1 Composition of solutions for permeabilized portal vein and aorta tissue studies (mM)
Relaxing Activating Rigor ATPS-relaxing ADP-activating Pi-activating Rigor apyrase
Ca2 0.02 5.26 0.02 0.02 5.32 5.25 0.02
Mg2 1.00 1.00 1.00 1.00 1.00 1.00 1.00
CP 25.00 25.00 0.00 0.00 0.00 0.00 0.00
MgATP 5.00 5.00 0.00 0.00 5.00 5.00 0.00
ADP 0.00 0.00 0.00 0.00 5.00 0.00 0.00
Pi 0.00 0.00 0.00 0.00 0.00 0.00 0.00
MgATPS 0.00 0.00 0.00 1.00 0.00 0.00 0.00
Apyrase 0.00 0.00 0.00 17.1 U 0.00 0.00 17.1 U
EGTA 5.00 5.00 5.00 5.00 5.00 5.00 5.00
KMS 69.24 58.61 171.22 165.59 113.53 109.10 171.22
BES 25.00 25.00 25.00 25.00 25.00 25.00 25.00
Concentrations of individual components are free concentrations and are calculated as described in Brozovich and Yamakawa (1995), using binding
constants per Andrews et al. (1991). Calmodulin (5 M) was added to all solutions.
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apyrase. Apyrase catalyzes the hydrolysis of any endoge-
nous ATP and/or ADP in the permeabilized muscle strips
when bound to cross-bridges. In the portal vein, there was
no significant differences in stiffness (3 1%, n 4, Fig.
4 a) between rigor solution with apyrase and rigor solution.
On the other hand, in the aorta, the addition of apyrase to the
rigor solution increased stiffness (22  3%, n  4, Fig. 4
b) compared to rigor solution. These results support the idea
that for the aorta, in rigor solution, the cross-bridge popu-
lation is mixed, consisting of both A-M-ADP and A-M
states.
Active state
Compared to the relaxed baseline, calcium activation of
portal vein and aorta significantly increased stiffness from a
resting level of 17.5  2.4 N/m (n  8) to 66.3  4.1 N/m
(n  10) in the portal vein and from 47.5  4.2 N/m (n 
7) to 96.1  6.7 N/m (n  9) in the aorta (Fig. 5). This is
consistent with an increase in the number of actively cy-
cling, force-producing cross-bridges and is similar to re-
ports by others for skeletal (Goldman and Simmons, 1984),
cardiac (Barsotti and Ferenczi, 1988), and smooth (Somlyo
et al., 1988) muscle.
Phosphate release step and its association with
force production
The effect of increasing the relative population of the pre-
phosphate release state (Fig. 1, state a) in portal vein and
aorta was analyzed by measuring the change in force and
stiffness when the tissue preparation was transferred from
FIGURE 2 Stiffness profiles of rabbit portal vein and aorta from 1 to 100
Hz for 1% Triton-permeabilized tissue strips in relaxing solution (pCa 
9). These stiffness traces represent the relaxed state for the respective
tissues and were referenced as 0. All other states are represented as the
change from the relaxed state.
FIGURE 3 Representative traces of the percentage change in stiffness
for the portal vein and aorta as the tissue is transferred from relaxing
solution to ATP--S relaxing solution. The portal vein stiffness in relaxing
solution did not significantly change when incubated in ATP--S relaxing
solution, while aortic stiffness decreased 20%.
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activating solution to activating solution containing 12 mM
inorganic Pi. The increase in inorganic Pi resulted in a
decrease in force for both the portal vein (42  1%, n 
4, Fig. 6 a) and aorta (30  1%, n  3, Fig. 7 a). In
addition for the portal vein, stiffness also decreased (40
4%, n  4, Fig. 6 b), while in the aorta stiffness similarly
dropped (18  1%, n  4, Fig. 7 b). These results are
consistent with several published reports, which demon-
strate a decrease in force with the elevation of inorganic Pi
(Osterman and Arner, 1995; He et al., 1998).
ADP release step and force production
To investigate the role of ADP release in the cross-bridge
cycle and force production for portal vein and aorta, the
relative population of pre-ADP release cross-bridge states
(Fig. 1, states b and c) was increased using 5 mM MgADP.
In portal vein, when the preparation was moved from acti-
vating solution to activating solution with 5 mM MgADP,
steady-state force decreased slightly (2  1%, n  6, Fig.
8 a). Surprisingly, there was a large decrease (50  3%,
n  6, Fig. 8 b) in stiffness, suggesting the detachment of
actin-bound, low-force-producing cross-bridges. However,
in the aorta, transfer from activating solution to activating
solution with 5 mM MgADP decreased force (30  3%,
n  3, Fig. 9 a) and stiffness (28  3%, n  3, Fig. 9 b),
suggesting that the ADP release step is associated with force
production.
To determine whether the affect of 5 mM MgADP on
force and stiffness in the aorta was due to only the elevation
of MgADP and not to other factors, we performed two
different control experiments. First, we assessed the possi-
bility that the MgADP effect is reversible. When the aorta
FIGURE 4 Representative traces of the percentage change in stiffness
for the portal vein and aorta as the tissue is transferred from rigor solution
to rigor solution containing 17.1 units of apyrase. Portal vein stiffness in
rigor solution did not change significantly when incubated in the presence
of apyrase, while in this example the aorta stiffness increased by 25%.
FIGURE 5 Change in stiffness for the portal vein and aorta from the
relaxed state (pCa  9) upon calcium activation (pCa  4).
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was transferred from activating solution with 5 mM
MgADP to activating solution (Fig. 10 a), the aorta rede-
veloped force back to the original maximum Ca2 activated
level (n  4), which demonstrates that the MgADP effect is
reversible. Second, to show that this effect was not due to a
change in MLC20 phosphorylation, the skinned aortic strips
were first thiophosphorylated with ATP--S. After thio-
phosphorylation, the preparations were activated with
MgATP, and force rapidly increased (Fig. 10 b). After force
reached a steady state, the tissue strip was transferred to
activating solution with 5 mM MgADP and force fell
(26  1%, n  4), an effect similar to that obtained with
nonthiophosphorylated preparations. Again, this MgADP
effect was reversible with force redevelopment when the
preparation was transferred from activating solution with 5
mM MgADP to activating solution.
DISCUSSION
Relaxed state
When the tissue strips were transferred from the relaxing
solution to ATP--S relaxing solution with apyrase, stiff-
ness and force did not change for the portal vein but de-
creased for the aorta. These data suggest that in the aorta, a
population of attached cross-bridges exists in relaxing so-
lution. Because ATP--S is a nonhydrolyzable analog of
ATP (Goody et al., 1980), substitution of ATP--S for ATP
would detach any attached cross-bridges present in relaxing
solution and result in an increase in the population of
detached, AM-ATP--S cross-bridges. Detachment of
cross-bridges by ATP--S in relaxing solution would de-
crease overall stiffness, with force decreasing if these cross-
bridges were also in a force-producing state(s).
FIGURE 6 Force and stiffness pro-
file upon transfer of portal vein from
activating solution to activating solu-
tion with 12 mM inorganic Pi. (a)
Force profile of rabbit portal vein
upon transfer from relaxing solution
to activating solution, then to activat-
ing solution with 12 mM inorganic Pi,
and back to relaxing solution. There
was a decrease (42  1%, n  4) in
force when the portal vein strip was
transferred from activating solution to
activating solution with 12 mM Pi. (b)
Concurrent with the decrease in force
from activating solution to activating
solution with 12 mM Pi, stiffness de-
creased (40  4%, n  4), suggest-
ing that 12 mM Pi results in the de-
tachment of attached, force-producing
cross-bridges. Stiffness data were
taken at the time points marked by
arrows (A) and (B) in a.
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The existence of a population of attached cross-bridges in
the relaxed state has been proposed by previous work from
this laboratory (Shue and Brozovich, 1999). This previous
investigation demonstrated that in single portal vein cells,
the phase angle was consistent with the presence of an
energy-generating process in the relaxed state. However, in
portal vein tissue strips, we did not detect a change in the
stiffness when the preparation was moved from relaxing to
ATP--S relaxing solution (Fig. 3 a). Nevertheless, in aortic
tissue we were still able to detect changes in the stiffness
when the skinned aortic strip was transferred from relaxing
solution to ATP--S relaxing solution (Fig. 3 b). Therefore
in the aorta, the data suggest that there is a larger population
of attached cross-bridges in comparison to the portal vein in
relaxing solution. Because previous work from this labora-
tory has demonstrated that attached cross-bridges are
present in relaxing solution for single portal vein cells, we
suggest that for ATP--S relaxing solution, the lack of
change in stiffness for the portal vein compared to the aorta
could be attributable to a smaller population of attached
cross-bridges in relaxing solution.
It has been shown previously that MLC20 phosphoryla-
tion is required for detached cross-bridges to attach and
produce force (Brozovich and Yamakawa, 1995). However,
if a population of attached cross-bridges already exists in
relaxing solution, these cross-bridges can produce force by
moving through a force-generating step and consequently
increasing force without increasing MLC20 phosphorylation
(Brozovich and Yamakawa, 1995; Shue and Brozovich,
1999). The existence of a population of attached cross-
FIGURE 7 Force and stiffness pro-
file upon transfer of aorta from acti-
vating solution to activating solution
containing 12 mM Pi. (a) Force pro-
file of rabbit aorta upon transfer from
relaxing solution to activating solu-
tion, and from activating solution to
activating solution with 12 mM Pi.
There was a decrease (30  1%,
n  3) in force when the aorta strip
was transferred from activating solu-
tion to activating solution with 12
mM Pi. 1, 2, and 3 indicate
changes in the solution. (b) Concur-
rent with the decrease in force from
activating solution to activating solu-
tion containing 12 mM Pi, stiffness
decreased (18  1%, n  4), sug-
gesting that 12 mM Pi results in the
detachment of attached, force-pro-
ducing cross-bridges. Stiffness data
were taken at time points marked by
arrows (A) and (B) in a.
Actomyosin ATPase in Smooth Muscle 1517
Biophysical Journal 79(3) 1511–1523
bridges could be the mechanism for those contractions that
occur without changes in MLC20 phosphorylation, such as
stimulation by phorbol esters (Jiang and Morgan, 1987) and
sodium hydrosulfite (Yu et al., 1998).
Rigor state
Several other investigators have shown the existence of a
population of A-M-ADP cross-bridges (either the A-M-
ADP or A-M-ADP* state) in rigor solution for both cardiac
(Martin and Barsotti, 1994) and smooth (Nishiye et al.,
1993) muscle. When the portal vein is transferred from rigor
solution to rigor solution with apyrase, the lack of change in
stiffness (Fig. 4 a) suggests that the portal vein in rigor
solution has a large population of cross-bridges in the rigor
(A-M) state. However, in the aorta, the change from rigor
solution to rigor solution with apyrase resulted in an in-
crease in stiffness (Fig. 4 b). These data suggest that for the
aorta, a population of A-M-ADP and/or A-M-ADP* cross-
bridges (Fig. 1) exists in rigor solution. Apyrase hydrolyzes
ADP and shifts the ADP-bound cross-bridges toward the
rigor (A-M) state, resulting in an increase in force as A-M-
ADP moves through the force-producing isomerization to
A-M-ADP* before entering the A-M cross-bridge state (Fig.
1, steps 5 and 6). Furthermore, the overall increase in
stiffness suggests that the apyrase treatment increases the
total number of attached cross-bridges.
These apyrase results demonstrate that in rigor solution
for the aorta, there exists a significant percentage of cross-
bridges in the ADP-bound states (A-M-ADP and/or A-M-
FIGURE 8 Force and stiffness pro-
file upon transfer of portal vein from
activating solution to activating solu-
tion with 5 mM MgADP. (a) Force
profile of rabbit portal vein upon
transfer from relaxing solution to ac-
tivating solution, from activating so-
lution to activating solution (-CP),
and from activating solution (-CP) to
activating solution with 5 mM
MgADP. For both portal vein and
aorta, changing from activating solu-
tion or activating solution (-CP) to
activating solution with 5 mM
MgADP did not change the results.
There was a small decrease in force
(2  1%, n  6) when the portal
vein strip was transferred from acti-
vating solution (-CP) to activating so-
lution with 5 mM MgADP. (b) A
decrease in stiffness (50 3%, n
6) was observed when the portal vein
strip was transferred from activating
solution to activating solution with 5
mM MgADP. Stiffness data were
taken at time points marked by ar-
rows (A) and (B) in a.
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ADP*). The existence of a significant population of ADP-
bound cross-bridges in rigor solution for aorta compared to
portal vein could be due to the difference in ADP affinity
and disassociation between phasic and tonic tissue (Arner et
al., 1987; Somlyo et al., 1988; Nishiye et al., 1993). The
isoforms of MLC17 have been correlated with the relative
sensitivities of the different smooth muscles types to
MgADP (Fuglsang et al., 1993). The concentration of the
more basic MLC17 isoform was highest in tonic tissue,
which also has the highest affinity for MgADP. In contrast,
phasic tissue predominantly expresses the acidic MLC17
isoform, which has a lower affinity for MgADP (Fuglsang
et al., 1993), faster shortening velocities (Malmqvist and
Arner, 1991), faster rates of force development (Horiuti et
al., 1989), and higher ATPase activity (Hasegawa and
Morita, 1992). In addition, the differences in the 7-amino
acid insert near the ATP binding site, which differs in phasic
and tonic smooth muscle myosin heavy chains (Kelley et
al., 1993; White et al., 1993), may also affect MgADP
affinity in phasic and tonic smooth muscle. Therefore, in
tonic tissue, a lower ADP Kd would result in a larger
population of MgADP-bound cross-bridges (A-M-ADP
and/or A-M-ADP*). ADP disassociation is higher in the
portal vein compared to the aorta (Khromov et al., 1996),
which may produce a nondetectable population of ADP-
bound cross-bridges in rigor solution. Others (Sweeney et
al., 1998) have also suggested that for tonic smooth
muscle, a lower Kd for ADP would result in a slower
cycling rate compared to phasic smooth muscle. This
could partially explain the slower force generation and
FIGURE 9 Force and stiffness pro-
file upon transfer of rabbit aorta from
activating solution to activating solu-
tion with 5 mM MgADP. (a) Force
profile of aorta upon transfer from
relaxing solution to activating solu-
tion, and from activating solution to
activating solution with 5 mM
MgADP. There was a decrease
(30  3%, n  3) in force when the
aorta strip was transferred from acti-
vating solution to activating solution
with 5 mM MgADP. 2 and 3 in-
dicate subsequent changes to fresh ac-
tivating solution containing 5 mM
MgADP. (b) Concurrent with the de-
crease in force with the transfer from
activating solution to activating solu-
tion with 5 mM MgADP, stiffness
decreased (28  3%, n  3). Stiff-
ness data were taken at time points
marked by arrows (A) and (B) in a.
Actomyosin ATPase in Smooth Muscle 1519
Biophysical Journal 79(3) 1511–1523
lower ATPase activity of tonic compared to phasic smooth
muscle.
Active state
The large increase in force and stiffness (Fig. 5) for both the
portal vein and aorta is consistent with an increase in the
number of cycling, force-producing cross-bridges during
activation. As expected, force production was faster in the
portal vein than in the aorta, consistent with their phasic and
tonic properties, respectively. Similar increases in force and
stiffness have been reported by others (Somlyo et al., 1988).
Phosphate release
Phosphate release has been shown to be regulated by
MLC20 phosphorylation (Sellers, 1985) and, in smooth
muscle, is thought to occur concurrently with or just before
cross-bridge attachment and force generation (Fig. 1, step
4). Thus inhibition of Pi release should inhibit cross-bridge
attachment and increase the relative population of the
AM-ADP-Pi state (Fig. 1, state a). If inhibition of Pi
release occurs with the elevation of Pi, one would predict
that force and stiffness should fall proportionally. Similar to
studies in skeletal (Kawai et al., 1987; Pate et al., 1998),
cardiac (Barsotti and Ferenczi, 1988), and smooth (Itoh et
al., 1986; Osterman and Arner, 1995) muscle, we have
demonstrated that elevating Pi decreases force and stiffness.
Our results for both the portal vein (Fig. 6) and aorta (Fig.
7) suggest that elevation of Pi decreases steady-state force
and stiffness by increasing the relative population of the
weakly bound or detached AM-ADP-Pi state.
Others (Brozovich et al., 1988) have suggested that in
skeletal muscle there exists an attached but low-force A-M-
FIGURE 10 (a) Force profile upon
transfer of rabbit aorta from relaxing
to activating solution, from activating
solution to activating solution with 5
mM MgADP, and back to activating
solution. Force increased to the orig-
inal maximum force when aorta was
transferred from activating solution
with 5 mM MgADP to activating so-
lution (n  4). (b) Force profile upon
transfer from ATP--S rigor solution
to activating solution, and from acti-
vating solution to activating solution
with 5 mM MgADP solution. Force
decreased (30  3%, n  5) upon
exposure to 5 mM MgADP, which is
similar to the ADP response for non-
thiophosphorylated tissue.
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ADP-Pi state in addition to the detached, AM-ADP-Pi
state. If this state exists in smooth muscle, an increase in Pi
should shift the population of cross-bridge states and lead to
a relative increase in the attached, low-force-producing A-
M-ADP-Pi state. An increase in the relative population of an
attached but low-force-producing A-M-ADP-Pi state should
produce a smaller fall in stiffness than in force. In the portal
vein, elevation of Pi produced a proportionate fall in stiff-
ness and force. These results suggest that a low-force A-M-
ADP-Pi does not exist for the portal vein (Fig. 1). However,
in the aorta, stiffness decreased by 18% while force fell by
30%, a fall in stiffness that is 40% less than the fall in force.
This suggests that an attached, low-force-producing A-M-
ADP-Pi cross-bridge state may exist in the aorta. Conse-
quently, for tonic smooth muscle, the cross-bridge model in
Fig. 1 requires modifications to include this potential state
(Fig. 11, state a.2).
ADP release
Cooke and Pate (1985) have demonstrated in skeletal mus-
cle fibers that force increases when the fiber is transferred
from activating solution to activating solution with elevated
MgADP, which suggests that force is produced before ADP
release from the cross-bridge. However, recent literature
(Whittaker et al., 1995; Gollub et al., 1996; Jontes and
Milligan, 1997) suggests that in smooth muscle the binding
of MgADP to the cross-bridge is associated with a confor-
mational change in the light-chain domain, resulting in a
significant movement of the head-rod junction. This change
represents an extra movement of smooth muscle S1 beyond
that of skeletal muscle S1 (Whittaker et al., 1995; Gollub et
al., 1996). If there is force production associated with the
extra movement of the S1 head by ADP release, then ele-
vating MgADP to increase the relative population of the
A-M-ADP states should decrease force.
Portal vein
When portal vein tissue was transferred from activating
solution to activating solution containing 5 mM MgADP,
there was a small decrease in force but a large, 50%
decrease in stiffness (Fig. 8 b). Therefore, for the portal
vein, our data suggest that ADP release is not a force-
producing step (Fig. 1, step 6). This correlates with similar
reports for other phasic smooth muscle (Khromov et al.,
1996) and fits well with the original cross-bridge model
scheme presented by Fuglsang et al. (1993). This cross-
bridge scheme (Fig. 1) suggests that the force-generating
step is an isomerization from the low-force to the high-force
A-M-ADP state (Fig. 1, step 5). Similar to our results,
Dantzig et al. (1999) reported a decrease in stiffness when
rigor tissue was exposed to elevated MgADP. The large
decrease (50%) in stiffness we observed when transfer-
ring the portal vein tissue from activating solution to acti-
vating solution containing 5 mM MgADP suggests that
elevated MgADP preferentially affects low-force-producing
cross-bridges (Fig. 1, state b), leading to their detachment
(Fig. 1, state a). Detachment of low-force-producing cross-
bridges (Fig. 1, state b) can be explained by the cross-
bridges exiting backward out of the cross-bridge cycle with
subsequent detachment (Fig. 1, reversal of step 4), or,
alternatively, by the existence of a separate, detached
AM-ADP state (not shown), as suggested by the model of
Piazzesi et al. (1993). According to Piazzesi et al. (1993), an
intermediate, detached state (AM-ADP) exists that would
allow the attached, ADP-bound cross-bridges (Fig. 1, states
b and c) to detach without moving backward to the AM-
ADP-Pi state (Fig. 1, state a) and reattach to actin without
ADP dissociation. This type of mechanism can be used to
explain the multiple steps of the myosin head per hydrolysis
of a single ATP (Lombardi et al., 1992; Kitamura et al.,
1999).
Aorta
In the aortic preparations, transferring the tissue from acti-
vating solution to activating solution with 5 mM MgADP
decreased force and stiffness proportionally (Fig. 9), sug-
gesting that the elevation of MgADP decreases force and
detaches cross-bridges. These results were surprising, par-
ticularly because the release of ADP has not generally been
thought to be coupled to a major portion of the powerstroke.
However, if the extra 28° angle shift in the smooth muscle
FIGURE 11 Proposed cross-bridge
model for tonic smooth muscle as
adopted from Fuglsang et al. (1993).
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S1 resulting from MgADP release is associated with a
significant portion of the force-producing step(s) (Whittaker
et al., 1995; Gollub et al., 1996; Jontes and Milligan, 1997),
elevation of ADP concentrations should prevent ADP re-
lease and thus result in a fall in force. The explanation for
the decrease in stiffness with the transfer from activating
solution to activating solution with 5 mM MgADP could be
similar to that above for the portal vein: by the cross-bridge
exiting backward out the cycle (reversal of step 4, Fig. 1) or
through a detached AM-ADP state (Piazzesi et al., 1993).
In the aorta, given that our data suggest that a significant
portion of the force-producing step is associated with ADP
release, the subsequent rigor (A-M) state has to be a force-
producing state (Fig. 1, state e). However, ATP-induced
detachment from the rigor (A-M) state has been shown to
occur at a rate of 105 M1 s1 (Nishiye et al., 1993;
Khromov et al., 1996). At 5 mM ATP, the rate of cross-
bridge detachment would occur at 500 s1. Thus the rigor
(A-M) state would be very short lived and produce little or
no force. To maintain force, these data suggest that a sep-
arate, force-producing rigor state (A-M*; Fig. 11, state d)
would have to exist that is similar to that suggested by
measurements of force and ATPase activity of single myo-
sin S1 heads (Ishijima et al., 1998).
CONCLUSIONS
The data suggest that for tonic smooth muscle, the ADP
affinity for the cross-bridge is higher than that for phasic
smooth muscle. Our data also suggest that the force-gener-
ating mechanism, specifically the state involved, is not the
same for the portal vein and aorta. For portal vein, our data
are consistent with force production occurring concurrently
with and/or after Pi release, but before ADP release, which
fits well with the cross-bridge model presented in Fig. 1
(Fuglsang et al., 1993). For the aorta, our data suggest that
an attached, low-force A-M-ADP- Pi state exists and that a
significant portion of the cross-bridge power stroke is linked
with the ADP release. Thus in the aorta, the cross-bridge
model in Fig. 1 must include the attached, low-force A-M-
ADP-Pi and the attached, high-force A-M* states (Fig. 11,
states a.2 and d, respectively). These differences in cross-
bridge properties could account for the mechanical differ-
ences between phasic and tonic smooth muscle.
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